Iceland· IS-EU/1/23/1748/002
TALVEY
A talquetamab product containing talquetamab, registered in Iceland by Janssen-Cilag International NV*. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Talquetamab is registered in 12 of 19 countries.
Countries holding a registration under ATC L01FX29 (talquetamab), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Talquetamab · ATC L01FX29
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of talquetamab costs, country by country.
Normalised to the WHO defined daily dose (4 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Talquetamab · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$571.23
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Talquetamab
- Manufacturer
- Janssen-Cilag International NV*
- Country
- Iceland (IS)
- ATC code
- L01FX29
- ATC class
- Talquetamab
- Defined daily dose
- 4 mg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean4531941 ml x1 hglISK 849228
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Talquetamab in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTalvey 40 mg/mlJanssen-Cilag International
- SwitzerlandTalvey 40 mg/1.0 ml, InjektionslösungJanssen-Cilag AG
- CzechiaTALVEYJanssen-Cilag International N.V., Beerse
- SpainTALVEY 40 MG/ML SOLUCION INYECTABLEJanssen-Cilag International N.V
- NorwayTalveyJanssen-Cilag International N.V.
- PolandTalveyJanssen-Cilag International N.V.
- SwedenTALVEY 40 mg/ml Injektionsvätska, lösningJanssen-Cilag International NV
- United StatesTALVEYJanssen Biotech, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Talvey
- Norway · Talvey
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/181bb691-e482-4f51-a64c-1200d5b5a8ce GET /v1/drugs/181bb691-e482-4f51-a64c-1200d5b5a8ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn",
"source": "lyfjastofnun",
"atc_raw": "L01FX29",
"marketed": true,
"strength": "40 mg/ml",
"ma_number": "EU/1/23/1748/002",
"substance": "Talquetamab",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "45159"
}See everything about talquetamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.